Calphostin C is a potent inhibitor of protein kinase C and can induce Ca2+-
dependent apoptosis in human ALL cells. Further development of calphostin C
will require detailed pharmacodynamic studies in preclinical animal models
. Therefore, we established a sensitive and accurate high-performance liqui
d chromatography (HPLC)-based quantitative detection method for the measure
ment of calphostin C levels in plasma Extraction of calphostin C from plasm
a was performed by precipitation of plasma protein using acetonitrile and a
n aliquot of extracted supernatant was injected onto a Hewlett-Packard HPLC
system constituting a 250X4 mm LiChrospher 100, RP-18 (5 pm) in conjunctio
n with a 4X4 mm LiChrospher 100, RP-18 guard column (5 mu m). The eluted co
mpounds were detected by diode array detection set at a wavelength of 479 n
m. Acetonitrile-water containing 0.1% trifluoroacetic acid and 0.1% triethy
lamine (70:30, v/v) was used as the mobile phase. The average extraction re
covery from plasma was 97.3%. Good linearity (r>0.999) was observed through
out the concentration range of 0.05-40 mu M for calphostin C in 50 mu l of
plasma. Intra- and inter-assay variabilities were less than 6% in plasma. T
he lowest detection limit of calphostin C in 50 mu l plasma was 0.02 mu M a
t a signal-to-noise ratio of similar to 3. The availability of this assay w
ill now permit detailed pharmacodynamic and pharmacokinetic studies of calp
hostin C in vivo. (C) 1999 Elsevier Science B.V. All rights reserved.